シクロオキシゲナーゼ2
Prostaglandins Leukot. Essent. Fatty Acids 66 (1): 13–8. (January 2002). doi:10.1054/plef.2001.0335. PMID 12051953.
“Cyclooxygenase-2 and gastric carcinogenesis”. APMIS 111 (10): 915–25. (October 2003). doi:10.1034/j.1600-0463.2003.1111001.x. PMID 14616542.
“Role of cyclooxygenase-2 in colorectal cancer”. Cancer Metastasis Rev. 23 (1–2): 63–75. (2004). doi:10.1023/A:1025863029529. PMID 15000150.
“Prevention of head and neck cancer: current status and future prospects”. Curr Probl Cancer 28 (5): 265–86. (2004). doi:10.1016/j.currproblcancer.2004.05.003. PMID 15375804.
“Chemoprevention in lung cancer”.
“Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells”. J. Steroid Biochem. Mol. Biol. 80 (2): 203–12. (February 2002). doi:10.1016/S0960-0760(01)00187-X. PMID 11897504.
“Expression and cellular localization of cyclooxygenases and prostaglandin E synthases in the hemorrhagic brain.”. J Neuroinflammation 8: 22. (2011). doi:10.1186/1742-2094-8-22. PMC 3062590. PMID 21385433. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062590/.
“Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers”.